NCT00987220View on ClinicalTrials.gov

Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Alzheimer's DiseaseDementia
Interventions
DRUG

Placebo

Oral

DRUG

donepezil (Aricept)

5mg oral

Trial Locations (1)

06511

Pfizer Investigational Site, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00987220 - Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid | Biotech Hunter | Biotech Hunter